• Users Online: 277
  • Print this page
  • Email this page
ORIGINAL ARTICLE
Year : 2018  |  Volume : 12  |  Issue : 2  |  Page : 125-135

Diagnosis and treatment of calcineurin inhibitor-induced pain syndrome in chronic Kidney disease Stage 5 transplantation


Division of Nephrology, Imam Khomeini Hospital Complex, College of Medicine, National University of Tehran Medical Sciences, Tehran, Iran

Correspondence Address:
Dr. Fateme Shamekhi Amiri
Division of Nephrology, Imam Khomeini Hospital Complex, College of Medicine, National University of Tehran Medical Sciences, Tehran
Iran
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/ijot.ijot_19_18

Get Permissions

Context: Musculoskeletal pain is a frequent manifestation in postrenal transplant recipients that caused by several diseases. Clinically used calcineurin inhibitors including cyclosporine A and tacrolimus can induce calcineurin inhibitor-induced bone pain syndrome which is characterized by severe pain, especially in both lower extremities. Aims: The aim of this study to investigate clinical studies about diagnostic and therapeutic modalities in renal transplant recipients. Settings and Design: In this retrospective study, patients with calcineurin inhibitor-induced pain syndrome after kidney transplantation were selected. Materials and Methods: This paper was searched via electronic PubMed and Google Scholar databases. Few full-text original articles in kidney transplant recipients were extracted. In this study, 18 articles were assessed for eligibility and 12 renal transplant recipients in 9 case reports were included. Statistical Analysis Used: Categorical variables as percentage, normally distributed measurements as mean ± standard deviation, and nonnormally distributed measurements as median and interquartile range were recorded. Results: Of 12 patients, 7 (58.3%) patients were male and 5 (41.6%) were female. At this study, bone magnetic resonance imaging (MRI) was diagnostic modality of choice. Radionuclide scintigraphy is also helpful. The most effective treatment of calcineurin inhibitor-induced pain syndrome consisted reduction dose of calcineurin inhibitors, calcineurin inhibitors change to another drug from the same drug class or mammalian target of rapamycin inhibitors. Conclusion: This study demonstrates that bone MRI is diagnostic modality of choice in patients with calcineurin inhibitor-induced pain syndrome. Moreover, reduction of calcineurin inhibitors and switching of immunosuppressants show the most effective treatment in these patients.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed954    
    Printed20    
    Emailed0    
    PDF Downloaded158    
    Comments [Add]    

Recommend this journal